← FDA DRUG APPROVALS

FDA ANDA · ANDA077306

ONDANSETRON HYDROCHLORIDE

Sponsor: APOTEX

APPLICATION
ANDA077306
TYPE
ANDA
ORIGINAL APPROVAL
2007-06-25
LATEST ACTION
2018-02-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ONDANSETRON HYDROCHLORIDEDiscontinued
ONDANSETRON HYDROCHLORIDE EQ 4MG BASE · TABLET · ORAL
ONDANSETRON HYDROCHLORIDEDiscontinued
ONDANSETRON HYDROCHLORIDE EQ 8MG BASE · TABLET · ORAL

Approval history

2018-02-26Labeling · Supplement 12 · standardAP
2018-02-26Labeling · Supplement 10 · standardAP
2018-02-26Labeling · Supplement 11 · standardAP
2014-12-19Labeling · Supplement 9 · standardAP
2014-12-19Labeling · Supplement 7 · standardAP
2014-12-19Labeling · Supplement 8 · standardAP
2014-12-19Labeling · Supplement 6 · standardAP
2014-01-27Labeling · Supplement 5 · standardAP
2007-06-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →